Saturday , January 23 2021

The story of one of the most terrible scandals in the history of large pharmaceutical companies



The history of large corporations appears to be fraught with suspicious agreements that have been made to increase profit margins at the expense of consumers, such as hiding fossil fuel companies for research on human-induced climate change, the tobacco industry's complicity in smuggling its own products , the Ford Motor Company memorandum on Pinto, one of the world's leading drug companies for HIV-infected blood products – familiar with them – for patients with hemophilia, many of whom died of AIDS later.

Experts believe that the origin of the AIDS virus dates back to the jungles of Cameroon, where it migrated from monkeys infected with the human immunodeficiency virus (Syndrome of the Syndrome of the Syndrome of Immunodeficiency Syria) or SIV to humans, eating them – not by sex, as they claim some rumors.

During a period in the early 20th century, it spread slowly in that region for decades, spreading through neighboring countries and slightly out of reach of outsiders, without attracting much attention around the world.

But the change began in the early 1970s when large cities in the United States showed cases of strange and mysterious illnesses that detracted from the health of their patients before they had secondary infection. By 1981, AIDS had spread a real depression.

There was little information about the virus at the time, except that it was linked to nightclubs, drugs and homosexuality, but in 1982 it was discovered that it was transmitted through the blood of the infected person. In July of that same year, the Centers for Disease Control and Prevention Diseases (CDCs) That three patients with pigs were infected with the virus.

The hemorrhagic disorder is a hereditary disorder in which the blood lacks the protein necessary for clotting and, without proper treatment, can be lethal and requires the regular administration of blood products, such as the eighth coagulant factor, guaranteed by the famous Bayer company. ) This company.

This section produced and distributed the eighth factor and was used to make huge amounts of blood plasma donated by up to 10,000 people, which means that few donors with HIV were enough to pollute those amounts.

The company also exacerbated the risk by ignoring federal legislation aimed at tackling the AIDS crisis by collecting donated blood samples from suspected individuals such as prisoners, high-risk gay men, and intravenous drug users.

As a result, thousands of patients with bleeding were reported by the New York Times as "one of the most horrific medical-related drug disasters in history."

The Centers for Disease Control and Prevention (CDC) warned in 1983 that these blood products seemed to be the cause of AIDS patients and began to manufacture thermally treated products to effectively eliminate the HIV virus, which had no effect, making them safe for injection. Kater released his own version in response and began distributing it in February 1984.

Of course, this was not economically viable for Bayer, whose warehouses were full of untested heat samples, and as its market in Europe and the United States rapidly declined, sought other areas to settle their wares.

While Kater sold safer products in the West, it sold unhealthy old stocks to Asian and Latin American regions such as Hong Kong, Taiwan, Argentina and Malaysia, and continued for more than a year, ignoring the growing evidence of these products.

However, some of these destinations showed interest in the new product. In 1984, a Hong Kong distributor asked about the thermally treated product, but Red Kater replied that he had to "consume the stock" of the products shipped before moving on to the alternative " better and safer. "

When the distributor himself made an emergency call to Kater's main office, demanding the heat-treated product in the midst of a general panic about AIDS, he was told that the amount available was too small for the "most important" patients.

But in 1985, an official official said that Far Eastern markets had stopped selling large quantities of the untreated product, and that the Kater division had suspended all shipping operations for this product. In July 1985.

Several years later, a Bayer spokesman told The New York Times that Katter's department acted "in a responsible, moral and humane way" distributing the untreated product thermally outside the country, but blamed the lack of plasma sources and deceleration in the approval of the new product. Denied by the official authorities of these countries.

AIDS tests were not available at the time, so it is almost impossible to estimate the number of patients with hemophilia in those less developed countries who contracted HIV infection, but records confirm that at least 100 of them were infected as a result of using non- heated from Hong Kong. Only Hong Kong and Taiwan, while The Atlantic reported that nearly half of the patients with hemophilia in the United States were infected with plasma.

Today there are tests and methods of analysis for the effective investigation of viruses such as HIV and hepatitis C. Transfusion is very rare and HIV infection is no longer a death sentence as a result of medical advances.


  • Translation: Sarah Waqaf
  • Verification: Patent pending
  • Edition: صهيب الأغبري


Source link